NOUVELLE COMPOSITION SYNERGIQUE UTILISEE DANS L'ART VETERINAIRE ET SON PROCEDE DE PREPARATION

LA COMPOSITION SE CARACTERISE EN CE QU'ELLE COMPREND LA 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE ETOU LA 2,4-DIAMINO-5-(3,4-DIMETHOXYBENZYL)PYRIMIDINE, LA 2,6-DIMETHOXY-4-SULFANILAMIDOPYRIMIDINE ET LA 8-HYDROXYQUINOLEINE. The invention relates to a synergistic veterinary composition and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SZAUDER-NEE-LAUKO HEDVIG, HEDVIG SZAUDER NEE LAUKO, SIMON FERENC DR, KAROLY MAGYAR, FERENC SIMON, MAGYAR KAROLY DR, FEKETE PAL DR, VARGA JANOS DR, JANOS EGRI, KATALIN ZUKOVICS NEE SUMO, ROMVARY ATTILA DR, ATTILA ROMVARY, PAL FEKETE, JANOS VARGA, EGRI JANOS, ZUKOVICS-NEE-SUMO KATALIN
Format:	Patent
Sprache:	fre
Schlagworte:	CHEMISTRY FODDER FOODS OR FOODSTUFFS HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LA COMPOSITION SE CARACTERISE EN CE QU'ELLE COMPREND LA 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE ETOU LA 2,4-DIAMINO-5-(3,4-DIMETHOXYBENZYL)PYRIMIDINE, LA 2,6-DIMETHOXY-4-SULFANILAMIDOPYRIMIDINE ET LA 8-HYDROXYQUINOLEINE. The invention relates to a synergistic veterinary composition and/or a fodder premix useful for preventing or curing bacterial, fungal and protozoic infection particularly occurring at poultry species. Furthermore the invention relates to a process for preparing same. The composition or premix contains 1 to 100 parts by mass of 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine and/or 1 to 100 parts by mass of 2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine as well as 1 to 100 parts by mass of 2,6-dimethoxy-4-sulfanilamidopyrimidine or a pharmaceutically acceptable salt thereof and 1 to 100 parts by mass of 8-hydroxyquinoline or a pharmaceutically acceptable acid addition salt thereof optionally in admixture with carrier(s) and/or additive(s) commonly used in the pharmaceutical industry or for the preparation of premixes.